The stocks that showed a little bit positive change on Thursday, are as follows: Aeterna Zentaris Inc. (NASDAQ:AEZS), Zogenix, Inc. (NASDAQ:ZGNX), MDU Resources Group Inc. (NYSE:MDU), Douglas Emmett Inc (NYSE:DEI)
Aeterna Zentaris Inc. (NASDAQ:AEZS), with shares inclined 2.10%, closed at $0.550.
Zogenix, Inc. (NASDAQ:ZGNX), with shares rose 2.08%, settled at $1.47.
MDU Resources Group Inc. (NYSE:MDU), with shares raised 2.06%, and closed at $21.82.
Douglas Emmett Inc (NYSE:DEI), enhanced 2.05%, and closed at $30.32.
Latest NEWS regarding these Stocks are depicted underneath:
Aeterna Zentaris Inc. (NASDAQ:AEZS)
Aeterna Zentaris Inc. (AEZS), declared that it has agreed to transfer its discovery library of roughly 100,000 unique compounds to the South Carolina Center for Therapeutic Discovery & Development (the Center) following a just concluded Material Transfer Contract. This Contract represents the starting of a long-term relationship between the Corporation and the Center, which is part of The Medical University of South Carolina (MUSC), that will result in the continued use of the library for the discovery of drug development candidates for the Corporation in the areas of oncology, neurology, endocrinology and women’s health. The Center may make the library accessible to all investigators in the University of South Carolina system without restriction on its use and will own any therapeutic compounds discovered outside the Corporation’s areas of therapeutic interest.
The Center has agreed to conduct screening and pre-clinical activities with respect to the library with a view toward submitting to the Corporation at least one development candidate in its areas of therapeutic interest per year during a ten-year period starting in 2018. The Corporation will receive the right of first refusal to license the development candidates.
Aeterna Zentaris Inc., a specialty biopharmaceutical corporation, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The corporation’s product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.
Zogenix, Inc. (NASDAQ:ZGNX)
Formerly on March 26, Zogenix, Inc. (ZGNX), declared that dosing has begun in patients enrolled in its Relday(TM) multi-dose Phase 1b clinical study. Relday is a proprietary, long-acting, subcutaneously injected formulation of risperidone being investigated for the treatment of schizophrenia.
The Corporation also plans to initiate efforts to secure an ex-U.S. planned development and commercialization partner for Relday during this development stage and is targeting an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) by early 2016. If accomplished, these milestones would position the Corporation to start a Phase 3 clinical study for Relday in 2016.
Brad Galer, M.D., chief medical officer of Zogenix, stated, “We are happy to move the Relday development program forward into this next clinical study. We expect the data to continue to demonstrate that Relday’s novel formulation has a differentiated product profile amongst presently marketed long-acting injections for the treatment of schizophrenia that should enhance the treatment for this patient population.”
Zogenix, Inc., a pharmaceutical corporation, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. Its marketed product comprises Zohydro ER, an extended-release formulation of hydrocodone for the treatment of severe chronic pain.
MDU Resources Group Inc. (NYSE:MDU)
MDU Resources Group Inc. (MDU), will webcast its first quarter 2015 earnings conference call May 5 following the release of its results.
The webcast will start at 10 a.m. EDT and can be accessed at www.mdu.com. Audio and webcast replays will be accessible. Audio will be accessible through May 19 at (855) 859-2056, or (404) 537-3406 for international callers, conference ID 12424597.
MDU Resources Group, Inc. operates as a diversified natural resource corporation in the United States. The corporation’s Electric segment generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming. As of December 31, 2014, it served about 138,000 residential, commercial, industrial, and municipal customers in 177 communities and adjacent rural areas.
Douglas Emmett Inc (NYSE:DEI)
Douglas Emmett Inc (DEI), declared that it plans to release its 2015 first quarter earnings results after the close of the stock market on Tuesday, May 5, 2015. A live conference call is planned for the following day, Wednesday, May 6, 2015, at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time. Jordan Kaplan, President and Chief Executive Officer, will host the call together with Theodore Guth, Chief Financial Officer, and Kevin Crummy, Chief Investment Officer.
Douglas Emmett, Inc., a real estate investment trust, owns and operates office and multifamily properties in California and Hawaii. As of December 31, 2007, the corporation’s office portfolio comprised of 48 properties and multifamily portfolio comprised of 9 properties.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
